213258 Overview of State Initiatives Advancing Evidence-Based Prescribing and Reducing Conflicts of Interest in Medical Care

Tuesday, November 10, 2009: 12:55 PM

Sharon Treat, JD , National Legislative Association on Prescription Drug Prices, Hallowell, ME
States are at the forefront of efforts to limit pharmaceutical and medical device industry financial influence on prescribing and medical care. Legislation enacted in the states includes prescriber education programs, disclosure of industry payments and gifts to prescribers, gift bans, licensing and regulation of industry sales detailers, limiting the use of prescriber data for marketing purposes, and marketing to children. This presentation will present an overview of these state initiatives and emerging trends in the states.

Learning Objectives:
1. Describe state initiatives and emerging trends in promoting evidence based prescribing. 2. Discuss comparative analysis and consumer education resources by states. 3. Identify efforts by the District of Columbia in enacting and implementing initiatives to promote evidence based medicine.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am Executive Director of an organization of state legislators developing policy on prescription drug issues. In this capacity I testify at public hearings both at the state and federal levels and present on pharmaceutical issues at conferences, and provide technical assistance to legislators in developing policy. I am myself a state legislator and have sponsored legislation on prescription drug pricing, marketing, and access.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.